An observational study in Proximal Humeral Fracture, sponsored by Vanderbilt University Medical Center. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-05-11.
Sponsored by Vanderbilt University Medical Center · Observational
Among 21 studies in Shoulder Fractures with a site in United States — 10 open to participants now, 13 under way, none of them phase 3. Shoulder Fractures · United States.
Among the 21 studies in Shoulder Fractures with a site in United States, this one is the 5th largest by planned enrollment of the 17 observational ones that give a count, is one of 3 that started in 2017, is one of 17 observational ones, reaches primary completion later than 5 of the 12 other live ones, and was the 4th registered.
113 studies on the registry are indexed under Shoulder Fractures; 30 are open to participants now.
Browse Shoulder Fractures studies →10 of the 21 studies in Shoulder Fractures with a site in United States are open now. Recruiting first, the newest first:
Exactech · Sites in United States
FX Shoulder Solutions · Sites in United States
Zimmer Biomet · Sites in United States, Japan, New Zealand
FX Shoulder Solutions · Sites in United States
Cooper Norcross Health · Sites in United States
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 18 Shoulder Fractures studies recruiting now, 13 (72%) set no upper age limit and 3 (17%) stop at 75 or younger; 4 take children under 18; 2 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
21 studies; the count open now beside each. This study's row is marked.
First in 2005; this study’s year is marked. 3 started in 2017.
This study's planned enrollment of 150 is above the median of 97 across 60 observational studies indexed under Shoulder Fractures.
Median enrollment 103 across the 4 interventional studies, 100 across the 17 observational. Of the 6 that completed or were terminated, 2 (33%) have results posted.
This tab as a report to print or save as PDF → With an account.
12 of 21 have an industry lead sponsor. The 10 most frequent:
Vanderbilt University Medical Center is the lead sponsor of 833 studies on the registry; 155 are open to participants now.
Of its 125 completed or terminated interventional studies of FDA-regulated products, 92 (74%) have results posted.
Vanderbilt University Medical Center has 1 study filed under Shoulder Fractures — fewer than ten, so there is no comparison to draw.
4 of the studies in Shoulder Fractures with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT03626038Zimmer BiometPost Market Clinical Follow-up (PMCF) Study of the A.L.P.S. Proximal Humerus Plating System | 2026-12 |
| NCT04113044AO Innovation Translation CenterGo Fit Fast, Recovery Trajectory Using PROMIS®, Linking PROMIS® | 2026-12-31 |
| NCT06133920Cooper Norcross HealthDuration of Immobilization After Reverse Total Arthroplasty for Proximal Humerus Fractures | 2027-02-01 |
| NCT05019664Zimmer BiometAffixus Natural Nail System Humeral Nail PMCF | 2027-08 |
Among the 21 studies in Shoulder Fractures with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of this study is to document the performance and clinical outcomes of the A.L.P.S® Proximal Humerus Plating System.
Specific Aims:
The purpose of this study is to document the performance and clinical outcomes of the A.L.P.S® Proximal Humerus Plating System.
Specific Aims:
Patients who have suffered a proximal humerus fracture that requires operative intervention using the A.L.P.S Proximal Humerus Plating System.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Cancer that has spread from where it began to other parts of the body. “Metastatic” cancer is cancer that has spread this way.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Metastases
Cancer that has spread from where it began to other parts of the body. “Metastatic” cancer is cancer that has spread this way.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
As part of their routine care, patients who have experienced a proximal humerus fracture that requires operative fixation will receive the A.L.P.S® Proximal Humerus Plating System. This study is an observational, prospective study that monitors the patient's pain, functional ability, and patient-reported outcomes.
Bone Material Strength
Measured by the Osteoprobe
Time frame: During surgical procedure
Bone Indentation Distance
Measured by the Osteoprobe
Time frame: During surgical procedure
Plan to share: No — No plan to make individual participant data available to other researchers.
No publications or documents are linked to this record.
Started Aug 2017 (actual). Primary completion is estimated for Dec 2031, 171 months after the start.
Of 30 observational studies under Shoulder Fractures, half reached primary completion within 83 months of starting (the median), counting those still running; a quarter within 37 and three quarters within 109. This study's planned 171 months is above that.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Vanderbilt University Medical Center →